Evidence map›Paper›PMID 30298093›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2018

(+)-Usnic Acid Inhibits Migration of c-KIT Positive Cells in Human Colorectal Cancer.

Wei Wu, Bing Hou, Changli Tang, Fucheng Liu, Jie Yang, Tao Pan, Ke Si, Deyun Lu, Xiaoxiang Wang, Jing Wang and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Hepatotoxicity of usnic acid and underlying mechanisms.Journal of environmental science and health. Part C, Toxicology and carcinogenesis · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Wei Wu *Department of Gastroenterology, Integrated Traditional Chinese Medicine and Western Medicine Hospital Affiliated to Chengdu University of Traditional Chinese Medicine/Chengdu First People's Hospital, Chengdu 610041, China.ORCID 0000-0003-2935-6660
Bing Hou *Department of Gastroenterology, Integrated Traditional Chinese Medicine and Western Medicine Hospital Affiliated to Chengdu University of Traditional Chinese Medicine/Chengdu First People's Hospital, Chengdu 610041, China.ORCID 0000-0001-8129-4386
Changli Tang *Chengdu Easton Biopharmaceuticals Ltd., Chengdu 611731, China.ORCID 0000-0002-6550-1901
Fucheng LiuDepartment of Gastroenterology, Integrated Traditional Chinese Medicine and Western Medicine Hospital Affiliated to Chengdu University of Traditional Chinese Medicine/Chengdu First People's Hospital, Chengdu 610041, China.ORCID 0000-0001-9526-3273
Jie YangDepartment of Gastroenterology, Integrated Traditional Chinese Medicine and Western Medicine Hospital Affiliated to Chengdu University of Traditional Chinese Medicine/Chengdu First People's Hospital, Chengdu 610041, China.ORCID 0000-0002-5630-9651
Tao PanDepartment of Gastroenterology, Integrated Traditional Chinese Medicine and Western Medicine Hospital Affiliated to Chengdu University of Traditional Chinese Medicine/Chengdu First People's Hospital, Chengdu 610041, China.ORCID 0000-0003-0278-4278
Ke SiDepartment of Gastroenterology, Integrated Traditional Chinese Medicine and Western Medicine Hospital Affiliated to Chengdu University of Traditional Chinese Medicine/Chengdu First People's Hospital, Chengdu 610041, China.ORCID 0000-0002-1168-5979
Deyun LuDepartment of Gastroenterology, Integrated Traditional Chinese Medicine and Western Medicine Hospital Affiliated to Chengdu University of Traditional Chinese Medicine/Chengdu First People's Hospital, Chengdu 610041, China.ORCID 0000-0001-6314-7462
Xiaoxiang WangDepartment of Gastroenterology, Integrated Traditional Chinese Medicine and Western Medicine Hospital Affiliated to Chengdu University of Traditional Chinese Medicine/Chengdu First People's Hospital, Chengdu 610041, China.ORCID 0000-0002-5027-2018
Jing WangDepartment of Gastroenterology, Integrated Traditional Chinese Medicine and Western Medicine Hospital Affiliated to Chengdu University of Traditional Chinese Medicine/Chengdu First People's Hospital, Chengdu 610041, China.ORCID 0000-0002-4902-7330
Xing XiongDepartment of Gastroenterology, Integrated Traditional Chinese Medicine and Western Medicine Hospital Affiliated to Chengdu University of Traditional Chinese Medicine/Chengdu First People's Hospital, Chengdu 610041, China.ORCID 0000-0002-5618-5433
Ji LiuDepartment of Gastroenterology, Integrated Traditional Chinese Medicine and Western Medicine Hospital Affiliated to Chengdu University of Traditional Chinese Medicine/Chengdu First People's Hospital, Chengdu 610041, China.ORCID 0000-0003-2706-8323
Chunguang XieSchool of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China.ORCID 0000-0002-3521-6181
Chengdu University of Traditional Chinese Medicine · CNWest China Medical Center of Sichuan University · CNXiaochang People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inhibition of tumor cell migration is a treatment strategy for patients with colorectal cancer (CRC). SCF-dependent activation of c-KIT is responsible for migration of c-KIT positive [c-KIT(+)] cells of CRC. Drug resistance to Imatinib Mesylate (c-KIT inhibitor) has emerged. Inhibition of mTOR can induce autophagic degradation of c-KIT. (+)-usnic acid [(+)-UA], isolated from lichens, has two major functions including induction of proton shuttle and targeting inhibition of mTOR. To reduce hepatotoxicity, the treatment concentration of (+)-UA should be lower than 10

Identifiers

PMID30298093
PMCPMC6157178
OpenAlexW2890660869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.